Cell line name |
A375-RMR |
Synonyms |
A375 RMR; A375 SKIN CJ1; A375-CJ1 |
Accession |
CVCL_A1VP |
Resource Identification Initiative |
To cite this cell line use: A375-RMR (RRID:CVCL_A1VP) |
Comments |
Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). Population: Caucasian. Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436). Selected for resistance to: ChEBI; CHEBI_75998; Trametinib (Mekinist; GSK1120212). Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511. |
Sequence variations |
- Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (DepMap=ACH-002001).
- Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
|
Disease |
Amelanotic melanoma (NCIt: C3802) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Hierarchy |
Parent: CVCL_0132 (A-375) Children:
|
Sex of cell |
Female |
Age at sampling |
54Y |
Category |
Cancer cell line |
STR profile |
Source(s): DepMap=ACH-002001
Markers:Amelogenin | X |
CSF1PO | 11,12 |
D3S1358 | 15,17 |
D5S818 | 12 |
D7S820 | 9 |
D8S1179 | 11,14 |
D13S317 | 11,14 |
D16S539 | 9 |
D18S51 | 12,17 |
D21S11 | 29,30 |
FGA | 22,23 |
Penta D | 9,15 |
Penta E | 10,12 |
TH01 | 8 |
TPOX | 8,10 |
vWA | 16,17 |
Run an STR similarity search on this cell line |
Publications | PubMed=31882401; DOI=10.1158/0008-5472.CAN-19-2330; PMCID=PMC7029677 Johannes C. Melms, Sreeram Vallabhaneni, Caitlin Elizabeth Mills, Clarence Yapp, Jia-Yun Chen, Eugenio Morelli, Patricia Waszyk, Sushil Kumar, Derrick Deming, Nienke Moret, Steven Rodriguez ...Show all 24 authors... , Kartik Subramanian, Meri Rogava, Adam N.R. Cartwright, Adrienne Luoma, Shao-Lin Mei, Titus Josef Brinker, David M. Miller, Alexander Spektor, Dirk Schadendorf, Nicolo Riggi, Kai W. Wucherpfennig, Peter Karl Sorger, Benjamin Izar; Show fewer authors Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activity. Cancer Res. 80:798-810(2020) |
Cross-references |
Cell line databases/resources |
cancercelllines; CVCL_A1VP
Cell_Model_Passport; SIDM01935
DepMap; ACH-002001
|
Encyclopedic resources |
Wikidata; Q105506031
|
Entry history |
Entry creation | 12-Jan-2021 |
Last entry update | 19-Dec-2024 |
Version number | 10 |
---|